AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
66 hedge funds and large institutions have $40.6M invested in Asterias Biotherapeutics Inc. Series A in 2016 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 64 → 66 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
66
Holding in Top 10
1
Calls
$223K
Puts
$2K
Top Buyers
| 1 | +$444K | |
| 2 | +$332K | |
| 3 | +$292K | |
| 4 |
Morgan Stanley
New York
|
+$287K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$224K |
Top Sellers
| 1 | -$329K | |
| 2 | -$309K | |
| 3 | -$210K | |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$151K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$64.1K |